Structural and morphological changes of breast cancer cells induced by iron( ii ) complexes
Source abstract
Abstract
Metal-based complexes are well-established cancer chemotherapeutic drug candidates. Although our knowledge regarding their exact activity vs. toxicity profile is incomplete, changes in cell membrane biophysical properties and cytoskeletal structures have been implicated as part of the mechanism of action. Thus, in this work, we characterised the effects of iron(II)-based complexes on the structural and morphological properties of epithelial non-tumorigenic (MCF 10A) and tumorigenic (MDA-MB-231) breast cell lines using atomic force microscopy (AFM), flow cytometry and immunofluorescence microscopy. At 24 h of exposure, both the MCF 10A and MDA-MB-231 cells experienced a cell softening, and an increase in size followed by a re-stiffening at 96 h. In addition, the triple negative breast cancer cell line, MDA-MB-231, sustained a notable cytoskeletal and mitochondrial reorganization with increased actin stress fibers and cell-to-cell communication structures. An extensive all-atom molecular dynamic simulation suggests a possible direct and unassisted internalization of the metallodrug candidate, and confirmed that the cellular effects could not be ascribed to the simple physical interaction of the iron-based complexes with the biological membrane. These observations provide an insight into a link between the mechanisms of action of such iron-based complexes as anti-cancer treatment and cytoskeletal architecture.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Metal complexes synthesis and properties · Trace Elements in Health · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Université de Lorraine, LIBio, F-54000, Nancy, France
Université de Lorraine and CNRS, LPCME UMR 7564, F-54000 Nancy, France
Université de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France
Université de Lorraine and CNRS, L2CM UMR 7053, F-54000, Nancy, France
Université de Lorraine and CNRS, CRAN UMR 7039, F-54000 Nancy, France
Université de Paris, ITODYS, CNRS, F-75006, Paris, France
References (74)
Show source-provided references
1. Florea · Cancers · 2011 · 3 · 135110.3390/cancers3011351 ↗
2. Galluzzi · Cell Death Dis. · 2014 · 5 · e125710.1038/cddis.2013.428 ↗
3. Ghosh · Bioorg. Chem. · 2019 · 88 · 10292510.1016/j.bioorg.2019.102925 ↗
4. Yan · Chem. Commun. · 2005 · 476410.1039/b508531b ↗
5. Kostova · Curr. Med. Chem. · 2006 · 13 · 108510.2174/092986706776360941 ↗
6. Lazarević · Eur. J. Med. Chem. · 2017 · 142 · 810.1016/j.ejmech.2017.04.007 ↗
7. Bouché · Dalton Trans. · 2020 · 49 · 1145110.1039/D0DT02135K ↗
8. Fiorina · J. Med. Chem. · 1978 · 21 · 39310.1021/jm00202a016 ↗
9. Wang · Eur. J. Med. Chem. · 2020 · 190 · 11210910.1016/j.ejmech.2020.112109 ↗
10. Shoukat · Adv. Metallodrugs · 2020 · 11510.1002/9781119640868.ch4 ↗
11. Hillard · Angew. Chem., Int. Ed. · 2005 · 45 · 28510.1002/anie.200502925 ↗
12. Nguyen · Chimia · 2007 · 61 · 71610.2533/chimia.2007.716 ↗
13. Pigeon · New J. Chem. · 2011 · 35 · 221210.1039/c1nj20192a ↗
14. Cunningham · ChemBioChem · 2020 · 21 · 297410.1002/cbic.202000311 ↗
15. Ornelas · New J. Chem. · 2011 · 35 · 197310.1039/c1nj20172g ↗
16. Patra · Nat. Rev. Chem. · 2017 · 1 · 006610.1038/s41570-017-0066 ↗
17. C.Mejía , S.Ortega-Rosales and L.Ruiz-Azuara , in Biomedical Applications of Metals , Springer International Publishing , 2018 , pp. 213–23410.1007/978-3-319-74814-6_10 ↗
18. Spinello · Expert Opin. Drug Discovery · 2017 · 12 · 813
19. Wang · Curr. Opin. Chem. Biol. · 2020 · 55 · 17110.1016/j.cbpa.2020.02.006 ↗
20. Gattuso · Front. Chem. · 2015 · 3 · 6710.3389/fchem.2015.00067 ↗
21. Debnath · Methods · 2003 · 30 · 25610.1016/S1046-2023(03)00032-X ↗
22. Jeong · Oncol. Lett. · 2016 · 12 · 215310.3892/ol.2016.4852 ↗
23. Cailleau · Cancer Res. · 1974 · 34 · 801
24. Guck · Biophys. J. · 2005 · 88 · 368910.1529/biophysj.104.045476 ↗
25. Butcher · Nat. Rev. Cancer · 2009 · 9 · 10810.1038/nrc2544 ↗
26. Nagelkerke · Semin. Cancer Biol. · 2015 · 35 · 6210.1016/j.semcancer.2015.09.001 ↗
27. Lin · Oncotarget · 2015 · 6 · 2094610.18632/oncotarget.4173 ↗
28. Lekka · BioNanoScience · 2016 · 6 · 6510.1007/s12668-016-0191-3 ↗
29. Dutta · World J. Nano Sci. Eng. · 2019 · 09 · 110.4236/wjnse.2019.91001 ↗
30. Fiorin · Mol. Phys. · 2013 · 111 · 334510.1080/00268976.2013.813594 ↗
31. Phillips · J. Comput. Chem. · 2005 · 26 · 178110.1002/jcc.20289 ↗
32. Humphrey · J. Mol. Graphics · 1996 · 14 · 3310.1016/0263-7855(96)00018-5 ↗
33. Weiner · J. Comput. Chem. · 1986 · 7 · 23010.1002/jcc.540070216 ↗
34. Jorgensen · J. Chem. Phys. · 1983 · 79 · 92610.1063/1.445869 ↗
35. Wang · J. Mol. Graphics Modell. · 2006 · 25 · 24710.1016/j.jmgm.2005.12.005 ↗
36. Notaro · ChemMedChem · 2020 · 15 · 34510.1002/cmdc.201900677 ↗
37. Leonenko · Biochim. Biophys. Acta, Biomembr. · 2000 · 1509 · 13110.1016/S0005-2736(00)00288-1 ↗
38. El Kirat · Biochim. Biophys. Acta, Biomembr. · 2010 · 1798 · 75010.1016/j.bbamem.2009.07.026 ↗
39. Freudenthal · Biochim. Biophys. Acta, Biomembr. · 2016 · 1858 · 259210.1016/j.bbamem.2016.07.015 ↗
40. Sneddon · Int. J. Eng. Sci. · 1965 · 3 · 4710.1016/0020-7225(65)90019-4 ↗
41. Gavara · Nat. Nanotechnol. · 2012 · 7 · 73310.1038/nnano.2012.163 ↗
42. Polyakov · PLoS One · 2011 · 6 · 1888710.1371/journal.pone.0018887 ↗
43. Calzado-Martín · ACS Nano · 2016 · 10 · 336510.1021/acsnano.5b07162 ↗
44. Dutta · Breast Cancer: Basic Clin. Res. · 2020 · 14 · 1
45. Lincoln · Cytometry, Part A · 2004 · 59 · 20310.1002/cyto.a.20050 ↗
46. Lekka · Eur. Biophys. J. · 1999 · 28 · 31210.1007/s002490050213 ↗
47. Zhao · Oncogene · 2013 · 32 · 481410.1038/onc.2012.494 ↗
48. Santidrian · J. Clin. Invest. · 2013 · 123 · 106810.1172/JCI64264 ↗
49. Biel · Cell Death Dis. · 2020 · 11 · 46010.1038/s41419-020-2658-y ↗
50. Bergamo · Int. J. Oncol. · 2008 · 33 · 1281
51. Dhivya · BioMetals · 2015 · 28 · 92910.1007/s10534-015-9877-1 ↗
52. Lee · Int. J. Mol. Sci. · 2017 · 18 · 186910.3390/ijms18091869 ↗
53. Irace · Sci. Rep. · 2017 · 7 · 110.1038/srep45236 ↗
54. Pracharova · Dalton Trans. · 2018 · 47 · 1219710.1039/C8DT02236D ↗
55. R.Daniel , A.Mengeta , P.Bilodeau and J. M.Lee , bioRxiv , 2019
56. Agus · Sci. Rep. · 2013 · 3 · 1
57. Wang · Chin. J. Cancer · 2011 · 30 · 60310.5732/cjc.011.10226 ↗
58. Kostrhunova · J. Med. Chem. · 2019 · 62 · 517610.1021/acs.jmedchem.9b00489 ↗
59. long Xie · Cancer Sci. · 2018 · 109 · 368610.1111/cas.13830 ↗
60. Kashatus · Biochem. Biophys. Res. Commun. · 2018 · 500 · 910.1016/j.bbrc.2017.06.192 ↗
61. C.Mejía , S.Ortega-Rosales and L.Ruiz-Azuara , Biomedical Applications of Metals , ed. M. Rai , A. Ingle and S. Medici , Springer International Publishing , Berlin/Heidelberg, Germany , 2018 , vol. 10 , pp. 213–23410.1007/978-3-319-74814-6_10 ↗
62. Casini · Chem. Sci. · 2012 · 3 · 313510.1039/c2sc20627g ↗
63. Todd · Metallomics · 2009 · 1 · 28010.1039/b907567d ↗
64. Burger · Drug Resist. Updates · 2011 · 14 · 2210.1016/j.drup.2010.12.002 ↗
65. Johnstone · Chem. Rev. · 2016 · 116 · 343610.1021/acs.chemrev.5b00597 ↗
66. Pinheiro Araujo · Inorg. Chim. Acta · 2016 · 452 · 17010.1016/j.ica.2016.02.044 ↗
67. Kafer · Main Group Met. Chem. · 1997 · 20 · 1910.1515/MGMC.1997.20.1.19 ↗
68. Schiff · Nature · 1979 · 277 · 66510.1038/277665a0 ↗
69. Guéritte-Voegelein · J. Med. Chem. · 1991 · 34 · 99210.1021/jm00107a017 ↗
70. Bostancıoğlu · Drug Chem. Toxicol. · 2013 · 36 · 48410.3109/01480545.2013.776579 ↗
71. Wieczorek · ACS Med. Chem. Lett. · 2016 · 7 · 61210.1021/acsmedchemlett.6b00046 ↗
72. Pilon · Molecules · 2020 · 25 · 159210.3390/molecules25071592 ↗
73. Iacopetta · Appl. Sci. · 2021 · 11 · 562610.3390/app11125626 ↗
74. Acharya · Inorg. Chem. · 2021 · 60 · 341810.1021/acs.inorgchem.0c03820 ↗